Cerapedics announces commercial launch of i-FACTOR®+ Matrix in Canada for surgeries
WESTMINSTER -- Cerapedics announced the full commercial availability of i-FACTOR+ MATRIX for surgical implantation in Canada. "We are excited to announce that i-FACTOR+ Matrix is now fully... Read More
Friday November 6, 2020 0 comments
Cerapedics announces Canadian OK of its next-generation bone graft
WESTMINSTER -- Cerapedics, a private ortho-biologics company, today announced Health Canada approval of the company's next-generation bone graft called i-FACTOR+ Matrix, making it the first market... Read More
Tuesday September 15, 2020 0 comments
Cerapedics: FDA approves company's IDE supplement
WESTMINSTER -- Cerapedics announced the U.S. Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for... Read More
Friday July 24, 2020 0 comments
Cerapedics announces FDA approval of PMA supplement based on two-year clinical data
WESTMINSTER -- Cerapedics, a private ortho-biologics company, announced the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) supplement for i-FACTOR... Read More
Tuesday November 19, 2019 0 comments
Cerapedics appoints Patrick O’Connor VP of clinical and market development
WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the appointment of Patrick O'Connor as VP of Clinical and Market Development. "We are pleased to welcome... Read More
Tuesday June 25, 2019 0 comments
INterview with Jeffrey Marx, Cerapedics president and COO
Jeffrey (Jeff) G. Marx , Ph.D. is a senior executive with over 20 years of experience in the medical device space. His experience includes successful leadership roles spanning RD, business... Read More
Monday November 6, 2017 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
